Neuroplasticity in an Extended Amygdala Network as a Target Mechanism for Attention Bias Modification Outcome
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Marquette, Michigan, United States, 49855
- Northern Michigan University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Handedness (right handed)
- Normal Vision
- High Anxiety
- Preexisting Attentional Bias
Exclusion Criteria:
- No MRI contraindications
- No History of Head Injury
- No Neurological History
- Psychological History
- Limited Recreational Drug Use, No Abuse
- Limited Prescription Drug Use, No Abuse
- No Claustrophobia
- Not Pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Attention Bias Modification
|
Attention bias modification (ABM) sessions will consist of a modified dot-probe task that only contains incongruent trials (i.e., target-dot - neutral stimulus 100% pairing).
|
|
Active Comparator: Attention Control
|
Attention control (AC) sessions, will consist of a standard dot-probe task (i.e., target-dot - neutral/threat stimulus 50% pairing).
Thus, for AC participants, bias should remain the same, while ABM participants should show a reduced bias to threat.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attentional Bias
Time Frame: Baseline and after 6 weeks of the intervention
|
Reaction time difference to congruent and incongruent trials in the dot-probe task, which measure heightened attentional bias to threat.
|
Baseline and after 6 weeks of the intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State and Trait Anxiety
Time Frame: Baseline and after 6 weeks of the intervention
|
Anxiety as measured by the Speilberger State-Trait Anxiety Inventory
|
Baseline and after 6 weeks of the intervention
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MRI measures of gray matter volume
Time Frame: Baseline and after 6 weeks of the intervention
|
T1-weighted MRI measures of gray matter volume
|
Baseline and after 6 weeks of the intervention
|
|
MRI measures of structural and functional connectivity
Time Frame: Baseline and after 6 weeks of the intervention
|
Diffusion-tensor weighted MRI based measures of structural connectivity and functional MRI based measures of functional connectivity.
|
Baseline and after 6 weeks of the intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Joshua M Carlson, PhD, Northern Michigan University
Publications and helpful links
General Publications
- Carlson JM, Fang L, Koster EHW, Andrzejewski JA, Gilbertson H, Elwell KA, Zuidema TR. Neuroplastic changes in anterior cingulate cortex gray matter volume and functional connectivity following attention bias modification in high trait anxious individuals. Biol Psychol. 2022 Jul;172:108353. doi: 10.1016/j.biopsycho.2022.108353. Epub 2022 May 13.
- Carlson JM, Fang L. Attentional bias to threat and gray matter volume morphology in high anxious individuals. Cogn Affect Behav Neurosci. 2022 Jun;22(3):600-609. doi: 10.3758/s13415-021-00968-9. Epub 2021 Nov 9.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- HS13-555
- R15MH110951 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
NCT07351409Not yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking Anxiety
-
NCT03707158CompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety Disorders
-
NCT07230743RecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After Surgery
-
NCT07421063RecruitingAnxiety | Parental Anxiety
-
NCT07391020RecruitingAnxiety | Generalized Anxiety Disorder (GAD) | Worrying
-
NCT03585010CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of Childhood
-
NCT00534599CompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety States
-
NCT03821779Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and Fear
-
NCT04950088CompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
NCT04598230Active, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, Generalized
Clinical Trials on Attention Bias Modification
-
NCT06361095Recruiting
-
NCT04137367CompletedMajor Depressive Disorder
-
NCT02658682Completed
-
NCT03176004Completed
-
NCT03971903CompletedDepressive Disorder, Major
-
NCT02615717CompletedPosttraumatic Stress Disorder
-
NCT02018848CompletedObsessive-Compulsive Disorder
-
NCT01463137Completed